Dec. 06, 2002 09:18 AM
As Canada's biotech industry comes to grips with the ruling
that transgenic creations can't be patented, it's worth reading this summary
of recent articles on gene patents:
No other sector of the economy depends as much on strong patent protection or on the flow of information from academic science as pharmaceuticals and biotechnology.
is conference planner for the Open Source Convention, OSCON Europe, and other O'Reilly conferences. He was project manager for Perl 6, is on the board of The Perl Foundation, and is a frequent speaker on open source topics. He cowrote the bestselling Perl Cookbook.
Return to weblogs.oreilly.com.
Weblog authors are solely responsible for the content
and accuracy of their weblogs, including opinions they
express, and O'Reilly Media, Inc., disclaims any and
all liabililty for that content, its accuracy, and
opinions it may contain.
This work is licensed under a
Creative Commons License.